Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.8173
-0.0227 (-2.70%)
At close: Mar 19, 2026, 4:00 PM EDT
0.8190
+0.0017 (0.21%)
After-hours: Mar 19, 2026, 6:25 PM EDT

Heron Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
154245233255298931
Market Cap Growth
-60.33%5.18%-8.90%-14.24%-68.01%-51.81%
Enterprise Value
248.1339.87348.2351.63367.82930.8
Last Close Price
0.821.301.531.702.509.13
PE Ratio
--10.83-17.00-2.12-1.50-4.08
PS Ratio
0.991.581.612.012.7710.79
PB Ratio
11.5917.08-6.92-7.5221.9512.01
P/TBV Ratio
9.5115.12-6.93-6.9120.0611.59
P/FCF Ratio
--8.77-9.60-4.23-2.00-4.51
P/OCF Ratio
--8.87-10.33-4.35-2.03-4.58
EV/Sales Ratio
1.602.192.412.773.4210.78
EV/EBITDA Ratio
--1517.26-38.53-3.26-2.14-4.33
EV/EBIT Ratio
--133.91-30.20-3.18-2.11-4.27
EV/FCF Ratio
--12.18-14.37-5.83-2.47-4.51
Debt / Equity Ratio
9.819.81-5.19-5.2011.402.02
Debt / EBITDA Ratio
-627.85-627.85-19.67-1.67-0.92-0.74
Debt / FCF Ratio
-5.04-5.04-7.33-2.98-1.06-0.77
Net Debt / Equity Ratio
6.566.56-3.52-2.925.350.03
Net Debt / EBITDA Ratio
-419.67-419.67-13.11-0.92-0.42-0.01
Net Debt / FCF Ratio
-3.37-3.37-4.89-1.64-0.49-0.01
Asset Turnover
0.630.630.630.540.390.26
Inventory Turnover
0.570.570.811.351.071.02
Quick Ratio
1.421.421.511.761.662.72
Current Ratio
2.482.482.292.372.493.58
Return on Equity (ROE)
274.49%209.08%40.16%1083.86%-399.43%-140.53%
Return on Assets (ROA)
-1.04%-1.04%-5.06%-46.73%-62.75%-66.08%
Return on Invested Capital (ROIC)
-2.56%-2.56%-15.28%-145.62%-210.53%-329.80%
Return on Capital Employed (ROCE)
-1.68%-1.68%-8.10%-71.04%-86.63%-89.70%
Earnings Yield
-13.11%-9.23%-5.88%-47.06%-66.80%-24.53%
FCF Yield
-18.11%-11.40%-10.41%-23.62%-49.93%-22.16%
Buyback Yield / Dilution
-7.89%-7.89%-0.40%-11.65%-25.20%-0.76%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q